Relay Therapeutics to Announce Second Quarter 2026 Financial Results and Corporate Highlights on August 6, 2026
Relay Therapeutics announced it will report its second quarter 2026 financial results and corporate highlights on August 6, 2026. The clinical-stage precision medicine company is advancing small molecule therapies targeting cancer and genetic diseases, with a lead asset, zovegalisib, currently in Phase 3 trials for metastatic breast cancer and othe…